Hyaluronic acid injections for RSD: What the evidence shows
RSD is commonly used for what is now called complex regional pain syndrome type I (CRPS I), a chronic pain and nervous-system condition. It can cause pain far beyond an injured area, alongside swelling, unusual sweating, temperature or colour changes, stiffness and difficulty moving a limb. The label remains common in Australian patient communities, although CRPS is the more formal clinical term.
The appeal of RSD and hyaluronic acid injections is that treating a painful joint with a lubricating fluid may ease movement and reduce discomfort. This may help when a specific joint also has osteoarthritis, but it does not mean an injection can reset altered nerve responses or treat whole-body CRPS. Evidence for hyaluronic acid in CRPS is limited, so diagnosis, joint causes, risks, alternatives and expected benefits all matter.
Understanding RSD in modern practice
CRPS can follow a fracture, sprain, surgery, injection or period of immobilisation, although some cases have no obvious trigger. The nervous system appears to amplify pain and disturb the regulation of blood flow, sweating and movement. These changes can be regional, affecting an arm, hand, leg or foot.
Pain is often disproportionate to the original injury and may spread over time. Stiffness, weakness, tremor, muscle wasting, shiny skin, brittle nails and altered hair growth are possible features. The pattern varies between people, and a quiet period does not necessarily mean the underlying condition has resolved.
Chronic pain can also affect sleep, mood, work and close relationships. Anxiety or low mood can increase pain awareness and reduce confidence in movement. Conversely, gradually paced activity and practical support can improve function without requiring every symptom to disappear first.
What hyaluronic acid may do
Hyaluronic acid is a natural substance found in synovial fluid, the viscous liquid inside a joint. When injected into a joint, it is intended to supplement lubrication and may influence local inflammatory signalling. The procedure is called an intra-articular injection and does not act like a general pain tablet.
Most research on hyaluronic acid concerns osteoarthritis, especially knee disease, rather than CRPS. Results are mixed, and many studies compare different products, doses or schedules. Current evidence does not support routine hyaluronic acid injections as a core treatment for CRPS. If someone also has degenerative joint disease, targeted treatment might reduce mechanical joint pain without resolving the neurological features of RSD.
An injection can cause temporary soreness, swelling or a flare, while rare complications include infection, allergy or tissue injury. It may be unsuitable when there is active joint infection, significant skin disease or an uncertain diagnosis. Expected benefit should be defined around a specific function, such as walking a block or dressing, rather than a promise of curing chronic pain.
How doctors assess chronic joint pain
There is no single blood test or scan result that confirms CRPS. Diagnosis is usually clinical, based on the pattern of symptoms and response to the original injury. Doctors look for sensory, autonomic, motor and vasomotor changes, then consider other explanations. The Budapest criteria are commonly used to organise this assessment.
Imaging can reveal arthritis, fractures, infection or other structural problems, but it cannot by itself show CRPS. Sudden calf swelling, a hot swollen joint, fever, chest pain or breathlessness need prompt medical assessment rather than being labelled a normal RSD flare. A history of surgery, medication changes and previous injections also helps specialists interpret the pattern.
In Australia, a GP can refer a person to a rheumatologist, neurologist, pain specialist or rehabilitation physician. People in Sydney or Melbourne have access to larger multidisciplinary teams, while residents of regional NSW may combine local care with telehealth and travel to a major centre. Medicare rebates and private-health cover differ by service and policy, so expected costs should be confirmed before treatment.
Building a broader pain-management plan
Effective care usually combines several approaches: physiotherapy, occupational therapy, medicines, psychological support and careful pacing of activity. Physiotherapy may include gentle graded movement, desensitisation and coordination exercises, while occupational therapy can adapt tasks and equipment. Medicines are selected for individual symptoms and medical history because no single drug reverses CRPS.
Everyday Australian routines can place extra load on a sensitive limb. Long drives, gardening, standing at work, walking a dog and managing stairs may need adjustment, particularly during a flare. Pacing means alternating activity with rest before exhaustion, then increasing tolerable tasks gradually. It is not a test of endurance and should not push a person into prolonged severe pain.
A written plan for immediate flare-up steps can make changes in temperature, movement and positioning less confusing. Heat or cold may help some people, while others find them irritating, so comfort and skin checks matter. Support from a psychologist, chronic pain peer group or family can also reduce isolation and build sustainable coping strategies.
Making an informed treatment decision
The Australian market includes professionally administered hyaluronic acid products, over-the-counter joint supplements and private clinics offering different protocols. These are not interchangeable: an oral supplement cannot lubricate a joint in the same way, and an injection should not be purchased from an informal online seller. The Therapeutic Goods Administration oversees relevant therapeutic goods in Australia, while state workers compensation and return-to-work processes may apply if symptoms affect employment. Treatment choices also occur alongside other regional policy discussions, such as reporting on Bathurst pokie limits, reflecting the wider social environment experienced by patients in regional NSW.
- Bring a symptom and activity diary to appointments, noting pain, swelling, sleep changes, movement and possible triggers.
- Ask the treating clinician to confirm whether CRPS is the working diagnosis and whether a separate joint condition is present.
- Request a clear explanation of why hyaluronic acid is proposed, including the evidence, likely benefit timeframe, risks and alternatives.
- Check the practitioner’s qualifications, product, sterility procedures, aftercare and expected out-of-pocket cost.
- Agree on a functional goal and review date, with physiotherapy and pacing continuing even if an injection is scheduled.
If you are considering this treatment, book a GP or specialist review and bring your symptom diary, scan reports and medication list. Ask for a written plan covering what the injection is intended to improve, how long any benefit might last, possible side effects, costs and alternatives. Arrange urgent care for a hot, rapidly swollen joint, fever, sudden calf swelling, chest pain or breathlessness, as these can indicate problems that should not be attributed to RSD.